Covance’s Arizona toxicity plant on track
Contract research firm Covance has been given the green light for its $100m (€77m) animal testing and drug candidate development facility in Chandler, Arizona, US.
Archives for January 20, 2009
Jail and fine for faker whose drugs turned up in UK trials
A Chinese citizen has been fined more than $1.2m and sentenced to over six years in a US prison for distributing counterfeit drugs that appeared “identical to authentic pharmaceuticals”.
Teva and Lonza JV targets biosimilars
Teva has made a big push into the biosimilars market through a joint venture with Lonza, which will give the generics giant expertise in biologics manufacture.
PPD ends 2008 on a high
Pharmaceutical Product Development of the US is expecting to post a 12 per cent hike in revenues in 2009, helped by the recent opening of offices in Ireland and Singapore and new deals with Merck & Co.
FDA wants standardised drug pack numbering
The FDA is calling for all drugs to be labelled using a standardised numerical identifier (SNI) similar to the one suggested in the delayed California e-Pedigree guidelines in a bid to tighten up supply chain security.
Lonza adds $26m extra capacity at cell therapy plant
Lonza is spending $26m to expand capacity at its facility in Walkersville, Maryland, US as regulatory progress made with Osiris’ Prochymal looks set to kick start the era of cell therapies.